It’s no secret that Americans pay far more for prescription drugs than consumers in any other country in the developed world. Most European countries impose price controls on Big Pharma that keep their prescription drug prices to less than two-thirds of what Americans pay.
Obviously, Big Pharma doesn’t want that happening here — which may help to explain why Pfizer has funded a new Rand Corporation study saying that lowering drug prices through price controls would have horrific consequences for Americans.
How horrific? It would actually reduce the length of your life!
As Reuters reports:
Imposing European-style price controls on prescription drugs in the United States would result in modest cost savings that would be more than offset by shortened life spans as the pace of drug innovation slows, U.S. researchers said on Tuesday. They said lowering insurance co-payments would be a better way of attacking the problem of rising prescription drug prices in the United States, which pays more per capita for pharmaceuticals than any other nation.
“We found policies that regulate the prices of drugs could result in modest savings for consumers, in the best cases on the order of $5,000 to $10,000 per person over a lifetime,” said Darius Lakdawalla of the nonprofit Rand Corporation, who worked on two studies appearing in a special report on drug pricing in the journal Health Affairs.
“But in many other cases, those policies resulted in very substantial losses to consumers in the form of reduced life expectancy and those would be worth tens of thousands of dollars”…
They said introducing price regulations into a largely unregulated market like the United States would result in less investment in developing life-saving drugs, which in the long run would reduce the life expectancy of Americans.
I found it interesting that Pfizer’s funding of this little project was not mentioned until the 11th paragraph of the story.
I also found it interesting that there is no mention of the fact that in most European countries with prescription drug price controls, life spans are longer than in the United States.
Way to keep your eye on the ball, Reuters.
A final point to ponder: Rand says its study is objective. It just happens to put the burden of healthcare price reform on Big Insurance rather than Big Pharma, by saying the solution is to find a way to lower drug co-pays.
Do you think if the study had been funded by Humana or some other big insurance provider, Rand’s report might say something different?







One Response to Pfizer-funded study: Lower prescription drug prices could kill you
Leave a Reply Cancel reply
-
-
-
How to Safely Buy Prescription Drugs Online from Cary Byrd on Vimeo.
-
Search Blog Posts
-
Trending Content
-
Blogroll
- Bullet Wisdom
- Christian Social Network
- DrugWonks.com
- Eye on FDA
- GoozNews
- Health 2.0
- In the Pipeline
- Jesus Christ Our King
- Kevin, M.D.
- Pharm Aid
- Pharma Marketing
- PharmaGossip
- Pharmalot
- San Antonio Asphalt
- San Antonio Life Insurance
- San Antonio Pressure Washing
- The Angry Pharmacist
- The Health Care Blog
- The Peter Rost Blog
- World Vision
-
Tags
big pharma Canadian drugs canadian pharmacies canadian pharmacy consumer reports craig newmark divine healing Drug costs drug prices Drug reimportation eDrugSearch.com FDA Fosamax Generic drugs healing scriptures Health 2.0 healthcare reform Hypertension Jehova Rophe Jesus Christ Lipitor Metformin miracles nabp online pharmacy dictionary online prescriptions osteoporosis peter rost Pharmacies pharmacists pharmacychecker pharmacy spam phrma Prescription drug coupons Prescription drugs prescription medication Proverbs 3:5-8 reimportation relenza Roche saving money swine flu Tamiflu The Great Physician The Lord our Healer -
Archives
- July 2013 (12)
- June 2013 (8)
- May 2013 (8)
- April 2013 (8)
- March 2013 (10)
- February 2013 (14)
- January 2013 (6)
- August 2012 (2)
- July 2012 (1)
- June 2012 (1)
- April 2012 (6)
- March 2012 (3)
- February 2012 (1)
- January 2012 (2)
- November 2011 (2)
- June 2011 (2)
- August 2010 (1)
- July 2010 (2)
- June 2010 (2)
- May 2010 (3)
- April 2010 (4)
- March 2010 (5)
- February 2010 (4)
- January 2010 (1)
- November 2009 (2)
- October 2009 (6)
- September 2009 (7)
- August 2009 (11)
- July 2009 (12)
- June 2009 (18)
- May 2009 (14)
- April 2009 (10)
- March 2009 (13)
- February 2009 (10)
- January 2009 (10)
- December 2008 (24)
- November 2008 (22)
- October 2008 (27)
- September 2008 (28)
- August 2008 (23)
- July 2008 (30)
- June 2008 (32)
- May 2008 (29)
- April 2008 (27)
- March 2008 (19)
- February 2008 (26)
- January 2008 (35)
- December 2007 (23)
- November 2007 (26)
- October 2007 (36)
- September 2007 (25)
- August 2007 (33)
- July 2007 (36)
- June 2007 (31)
- May 2007 (32)
- April 2007 (22)
- March 2007 (22)
- February 2007 (29)
- January 2007 (18)
- December 2006 (56)
- November 2006 (16)
-
Recent Comments
- Sophie on Reclast’s “jaw problems” caused by too many warnings, spoken too quickly?
- Marcy on How to Get Coupons on Prescription Drugs
- Cary Byrd on Maine Becomes First State to Allow Prescription Drug Importation from Licensed Mail-Order Pharmacies
- brenda eppinette on Maine Becomes First State to Allow Prescription Drug Importation from Licensed Mail-Order Pharmacies
- Ranee on What is the Difference Between Effexor and Cymbalta?
This has to be the dumbest thing that Big Pharma has tried to say about the cost of prescriptions. Big co-pays are certainly not the issue here. It’s the people who can’t afford prescription coverage who are suffering when their drug bill is $200-300 for one month of some of these high-cost medications.